Karmanos Cancer Institute/Wayne State University — Detroit, Michigan

Karmanos Cancer Institute/Wayne State University is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Karmanos Cancer Institute/Wayne State University has participated in 4 clinical trials.

Therapeutic areas: Carcinoma, Non Small Cell Lung, Malignant Pleural Mesothelioma, Solid Tumors.

Sponsors: Pfizer, CanBas Co. Ltd., Duke University.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Institute/Wayne State University?

Karmanos Cancer Institute/Wayne State University has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Institute/Wayne State University conducted?

Karmanos Cancer Institute/Wayne State University has 4 clinical trials on record. Their work covers Carcinoma, Non Small Cell Lung, Malignant Pleural Mesothelioma, Solid Tumors.

Is Karmanos Cancer Institute/Wayne State University accredited by Crixeo Health?

Karmanos Cancer Institute/Wayne State University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Institute/Wayne State University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.